| Name | EGFR-IN-89 |
|---|---|
| Synonyms | Methanesulfonamide, N-[2-[[2-[[4-(4-ethyl-1-piperazinyl)-3-fluorophenyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]phenyl]-N-methyl |
| Description | EGFR-IN-89 (compound 13k) is a potent, fourth-generation EGFR mutation inhibitor with an IC50 of 10.1 nM against Del19/T790M/C797S mutations. EGFR-IN-89 shows higher selectivity over wild type[1]. |
|---|---|
| Related Catalog | |
| Target |
EGFR19del/TM/CS:10.1 nM (IC50) |
| References |
| Molecular Formula | C26H31FN8O2S |
|---|---|
| Molecular Weight | 538.64 |